Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;20(5):559-64.
doi: 10.1038/ejhg.2011.245. Epub 2012 Jan 11.

Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women

Affiliations

Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women

Alison Gartland et al. Eur J Hum Genet. 2012 May.

Abstract

The P2X7 receptor gene (P2RX7) is highly polymorphic with five previously described loss-of-function (LOF) single-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-function SNP (c.489C>T). The purpose of this study was to determine whether the functional P2RX7 SNPs are associated with lumbar spine (LS) bone mineral density (BMD), a key determinant of vertebral fracture risk, in post-menopausal women. We genotyped 506 post-menopausal women from the Aberdeen Prospective Osteoporosis Screening Study (APOSS) for the above SNPs. Lumbar spine BMD was measured at baseline and at 6-7 year follow-up. P2RX7 genotyping was performed by homogeneous mass extension. We found association of c.946A (p.Arg307Gln) with lower LS-BMD at baseline (P=0.004, β=-0.12) and follow-up (P=0.002, β=-0.13). Further analysis showed that a combined group of subjects who had LOF SNPs (n=48) had nearly ninefold greater annualised percent change in LS-BMD than subjects who were wild type at the six SNP positions (n=84; rate of loss=-0.94%/year and -0.11%/year, respectively, P=0.0005, unpaired t-test). This is the first report that describes association of the c.946A (p.Arg307Gln) LOF SNP with low LS-BMD, and that other LOF SNPs, which result in reduced or no function of the P2X7 receptor, may contribute to accelerated bone loss. Certain polymorphic variants of P2RX7 may identify women at greater risk of developing osteoporosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagrammatic representation of the protein structure of the P2X7R. The positions of amino acid changes as a result of the five polymorphisms included in this study are shown on the diagram. The three C-terminal and one ATP-binding site polymorphisms confer LOF (circles) while His155Tyr gives a weak GOF (triangle). The sixth polymorphism is located in intron 1.
Figure 2
Figure 2
Difference in annualised percentage change in LS-BMD. WT subjects (n=84); LOF, subjects who are have any LOF SNP but are WT at the c.489T GOF position (n=47); GOF, subjects who have a c.489T GOF SNP but WT at the LOF SNP positions (n=144). Individual values plotted with bars being the mean±SEM.

References

    1. Burnstock G, Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther. 2000;295:862–869. - PubMed
    1. Agrawal A, Buckley KA, Bowers K, et al. The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro. Purinergic Signal. 2010;6:307–315. - PMC - PubMed
    1. Bowler WB, Buckley KA, Gartland A, et al. Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone. 2001;28:507–512. - PubMed
    1. Buckley KA, Hipskind RA, Gartland A, et al. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. Bone. 2002;31:582–590. - PubMed
    1. Gartland A, Buckley KA, Bowler WB, et al. Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif Tissue Int. 2003;73:361–369. - PubMed

Publication types

Substances